Chemoresistance remains a major obstacle in improving responses to BTC treatment, and new drug combinations offer promising innovations to BTC patients
According to Eli Lilly, orforglipron is the first oral GLP-1 agonist, taken without food and water restrictions, to complete a phase 3 trial
10.1093/bioinformatics/btu671 61 WangX.LiuY.XiaoL.LiL.ZhaoX.YangL.et al (2018)
doi: 10.1530/eje.0.1330425 128 FrieboesMurckAntonijevicSteiger
Lips Correction Enhance lip shape, smooth vertical lines, and achieve a naturally plump, youthful look
Microarray Analysis Eight-week-old db/db mice and C57BL/6N mice were divided into Control group (C57BL/6N mice, n=10), Model group (db/db mice, n=10) and Geniposide group (db/db mice, n=10)